Ray Dalio Lantheus Holdings, Inc. Transaction History
Bridgewater Associates, LP
- $21.1 Billion
- Q4 2024
A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Bridgewater Associates, LP holds 109,678 shares of LNTH stock, worth $10.8 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
109,678
Previous 70,462
55.66%
Holding current value
$10.8 Million
Previous $7.73 Million
26.87%
% of portfolio
0.05%
Previous 0.04%
Shares
15 transactions
Others Institutions Holding LNTH
# of Institutions
533Shares Held
73.2MCall Options Held
598KPut Options Held
371K-
Black Rock Inc. New York, NY8.6MShares$844 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.24MShares$711 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X06.2MShares$609 Million0.29% of portfolio
-
Farallon Capital Management LLC San Francisco, CA5.32MShares$522 Million2.53% of portfolio
-
State Street Corp Boston, MA2.64MShares$259 Million0.01% of portfolio
About Lantheus Holdings, Inc.
- Ticker LNTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 68,741,904
- Market Cap $6.75B
- Description
- Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...